Patients showing red cell loss following severe burns have been considered in two groups, the more severe cases with late haemoglobinuria and the more numerous less severe cases without late haemoglobinuria. Patients who had late haemoglobinuria usually belonged to group A or AB, showed a normal or increased osmotic fragility of red cells, and had received more than three plasma volumes of pooled plasma. It is suggested that this haemolytic anaemia may have been caused by the anti-A isoagglutinins in pooled plasma or serum. Patients showing red cell loss but who had no late haemoglobinuria had a normal ABO group distribution and an increased osmotic resistance of their red cells. It is concluded that this more common type of red cell loss in burns is independent of transfused isoagglutinins. Isoantibodies present in pooled plasma have been investigated. Corresponding antibodies have been demonstrated in the serum of groups A and AB patients transfused with moderate quantities of pooled plasma. The same patients commonly also had a raised erythrocyte sedimentation rate, without there being a clinically important red cell loss.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC480491 | PMC |
http://dx.doi.org/10.1136/jcp.16.1.79 | DOI Listing |
Front Endocrinol (Lausanne)
January 2025
Department of Endocrinology, Affiliated Wujin Hospital of Jiangsu University, Changzhou, Jiangsu, China.
Background: Dyslipidemia is closely related to diabetic neuropathy. This study examined the potential causal relationship involving 179 lipid species and the disease.
Methods: The pooled data on 179 lipid species and diabetic neuropathy were obtained from previous genome-wide association studies (GWAS).
Cureus
December 2024
College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Chronic rhinosinusitis (CR) is a persistent inflammation of the nasal mucosa and paranasal sinuses. Endoscopic sinus surgery (ESS) is a procedure that improves sinus drainage and ventilation. Despite advancements in ESS, additional corrective procedures post-ESS are often needed.
View Article and Find Full Text PDFVox Sang
January 2025
Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
Background And Objectives: Access to blood components in pre-hospital bleeding resuscitation is challenging. Dried plasma is a logistically superior alternative, and new products are emerging. Therefore, we aimed to evaluate laboratory and practical differences in three differently produced dried plasma products.
View Article and Find Full Text PDFJ Pharm Sci
January 2025
Clinical Pharmacology, Pharmacometrics & Bioanalysis, Bristol Myers Squibb, Princeton, NJ, USA.
Iberdomide, a novel potent cereblon E3 ligase modulator, is under investigation for multiple myeloma. This study assessed how renal impairment (RI) affects iberdomide pharmacokinetics (PK). Twenty-six subjects with varying renal function, including those with severe renal impairment and those requiring intermittent hemodialysis (IHD), received a single oral 1 mg dose of iberdomide.
View Article and Find Full Text PDFPurpose: To evaluate the effect of osilodrostat and hypercortisolism control on blood pressure (BP) and glycemic control in patients with Cushing's disease.
Methods: Pooled analysis of two Phase III osilodrostat studies (LINC 3 and LINC 4), both comprising a 48-week core phase and an optional open-label extension. Changes from baseline in systolic and diastolic BP (SBP and DBP), fasting plasma glucose (FPG), and glycated hemoglobin (HbA) were evaluated during osilodrostat treatment in patients with/without hypertension or diabetes at baseline.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!